Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today its participation, through Matt Murphy’s appointment, in the newly formed National Cannabis Roundtable (“NCR”), a campaign aimed at reforming US federal cannabis laws. The NCR will focus on advocating for a rational legal framework for cannabis reform in the US with former Speaker of the House, John Boehner, serving as Honorary Chairman.
Matt Murphy, Khiron Vice President of Compliance, who will represent the Company on the NCR, stated, “With two-thirds of Americans indicating support for legalization of cannabis in some form, and safety and security being central to our mission across the entire supply chain, we believe that now is the time to work alongside our colleagues to inform and advocate for an open market that improves lives, creates jobs and establishes a national cannabis industry for the 21st century.”
As Vice President of Compliance for Khiron and former Chief of Pharmaceutical Investigations for the U.S. Drug Enforcement Administration (“DEA”), Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a career Special Agent with the DEA for 25 years, he served in a multitude of positions in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy directs the Company’s compliance activity by implementing closed loop systems to prevent product diversion and to enhance standard operating procedures across Khiron’s plant-to-patient value chain based on the DEA protocols used to enforce compliance for the handling and distribution of controlled substances in the U.S.
SOURCE Khiron Life Sciences Corp.